SCHEMBL3424976

SCHEMBL3424976

O=C(O)CCc1ccc(Oc2ccc(O)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 15/20 0.77
FFAR4 Q5NUL3 5/20 0.69
SRD5A2 P31213 1/20 0.66
PCNA P12004 1/20 0.65
ESR1 P03372 1/20 0.56
LMNA P02545 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Apteniol A SCHEMBL16431559 0.92 FFAR1 (0.89) FFAR1FFAR4SRD5A2LMNAL3MBTL1
SCHEMBL2349797 0.89 FFAR1 (0.62) FFAR1FFAR4SRD5A2PCNA
Hydroxyphenyl Propionic Acid SCHEMBL35486 0.88 FFAR1 (0.68) FFAR1FFAR4ESR1LMNA
SCHEMBL2774842 0.87 FFAR1 (1.00) FFAR1FFAR4SRD5A2
Hydroxyphenyl Propionic Acid SCHEMBL5606896 0.86 FFAR1 (0.65) FFAR1FFAR4ESR1LMNA
Hydroxyphenyl Propionic Acid SCHEMBL10712090 0.86 FFAR1 (0.65) FFAR1FFAR4ESR1LMNA
Hydroxyphenyl Propionic Acid SCHEMBL28184441 0.86 FFAR1 (0.65) FFAR1FFAR4ESR1LMNA
Hydroxyphenyl Propionic Acid SCHEMBL18263865 0.86 FFAR1 (0.65) FFAR1FFAR4ESR1LMNA
Hydroxyphenyl Propionic Acid SCHEMBL28123368 0.84 FFAR1 (0.63) FFAR1FFAR4ESR1LMNAL3MBTL1
SCHEMBL31322120 0.84 F2RL1 (0.64) FFAR1FFAR4SRD5A2PCNAESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240301134-A1 POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2024-09-12 US disclosed
US-12030983-B2 Polymeric biomaterials derived from phenolic monomers and their medical uses RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2024-07-09 US disclosed
EP-3394024-B1 POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES UNIV RUTGERS (US) 2023-08-02 EP disclosed
US-20230167238-A1 POLYMETRIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2023-06-01 US disclosed
US-11649203-B2 Polymeric biomaterials derived from phenolic monomers and their medical uses RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2023-05-16 US disclosed
US-11472918-B2 Polymeric biomaterials derived from phenolic monomers and their medical uses RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2022-10-18 US disclosed
CN-108834411-B Polymeric biomaterials derived from phenolic monomers and their medical uses 新泽西鲁特格斯州立大学 2022-01-25 CN disclosed
US-8476399-B2 Biocompatible polymers for medical devices RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2013-07-02 US disclosed
US-20130085238-A1 BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2013-04-04 US disclosed
US-8252887-B2 Biocompatible polymers for medical devices RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2012-08-28 US disclosed
US-20100234555-A1 BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES RUTGERS, THE STATE UNIVERSITY (US) 2010-09-16 US disclosed
WO-2010042918-A1 BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-04-15 WO disclosed
WO-2007008603-A1 MONOMETHYLVALINE COMPOUNDS HAVING PHENYLALANINE SIDE-CHAIN MODIFICATIONS AT THE C-TERMINUS SEATTLE GENETICS, INC. (US) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12030983-B2 Polymeric biomaterials derived from phenolic monomers and their medical uses TH, TYR, MYB FFAR1 1224/4885FFAR4 1684/4885SRD5A2 4117/4885
US-20240301134-A1 POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES TH, TYR, MYB FFAR1 1383/4885FFAR4 1881/4885SRD5A2 4118/4885
US-20100234555-A1 BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES ECPAS, PTGIR, RXFP1 FFAR1 827/4885FFAR4 1951/4885SRD5A2 4701/4885
US-11649203-B2 Polymeric biomaterials derived from phenolic monomers and their medical uses TH, TYR, TYRO3 FFAR1 2023/4885FFAR4 2299/4885SRD5A2 3847/4885
US-11472918-B2 Polymeric biomaterials derived from phenolic monomers and their medical uses TH, TYR, MYB FFAR1 1383/4885FFAR4 1881/4885SRD5A2 4118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.